MASTINI, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 726
EU - Europa 427
AS - Asia 192
AF - Africa 6
OC - Oceania 2
SA - Sud America 1
Totale 1.354
Nazione #
US - Stati Uniti d'America 713
IT - Italia 128
CN - Cina 119
SE - Svezia 63
IE - Irlanda 55
UA - Ucraina 36
FR - Francia 32
DE - Germania 31
FI - Finlandia 27
AT - Austria 21
SG - Singapore 21
KR - Corea 19
VN - Vietnam 16
CA - Canada 13
PL - Polonia 12
BE - Belgio 7
GB - Regno Unito 6
JP - Giappone 6
SN - Senegal 4
TW - Taiwan 3
ES - Italia 2
GR - Grecia 2
NL - Olanda 2
RU - Federazione Russa 2
TR - Turchia 2
AU - Australia 1
BR - Brasile 1
BY - Bielorussia 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
KZ - Kazakistan 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 1.354
Città #
Chandler 135
Beijing 80
Dublin 55
Ann Arbor 38
Fairfield 38
Houston 38
Ashburn 37
Torino 36
Jacksonville 28
Villeurbanne 24
Woodbridge 22
Fremont 21
Vienna 21
Nyköping 20
Medford 18
Wilmington 18
Cambridge 17
Dearborn 16
Dong Ket 14
Princeton 14
Seattle 14
Warsaw 12
Düsseldorf 11
Milan 10
Pisa 10
Singapore 10
Turin 10
Boardman 8
Boston 8
Brussels 7
Ottawa 7
New York 6
Chengdu 5
Shanghai 5
Toronto 5
Grafing 4
Guangzhou 4
Norwalk 4
Catania 3
Hangzhou 3
Redwood City 3
Rome 3
Tokyo 3
Varese 3
Verona 3
Alba 2
Ankara 2
Colmenar Viejo 2
Falls Church 2
Florence 2
Genoa 2
Hefei 2
Helsinki 2
Jinan 2
Lanzhou 2
Lissone 2
Los Angeles 2
New Haven 2
Occimiano 2
Palermo 2
Seoul 2
Taipei 2
Upper Marlboro 2
Washington 2
Xian 2
Zhengzhou 2
Albuquerque 1
Almaty 1
Anzio 1
Ardabil 1
Aurora 1
Baltimore 1
Bologna 1
Cape Town 1
Carlsbad 1
Castelbellino 1
Cedar Knolls 1
Changchun 1
Changsha 1
Chongqing 1
Christchurch 1
Cincinnati 1
Cuceglio 1
Harbin 1
Hebei 1
Kumamoto 1
Köln 1
Las Vegas 1
Lexington 1
Maywood 1
Minerbe 1
Monmouth Junction 1
Nuremberg 1
Phoenix 1
Piemonte 1
Recife 1
Reggio Nell'emilia 1
San Antonio 1
San Jose 1
San Mateo 1
Totale 927
Nome #
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency 233
Efficacy of a Cancer Vaccine against ALK-Rearranged Lung Tumors 210
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma 98
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins 95
A better immune reaction to Erbb-2 87
The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination 85
ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis 83
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 81
Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice 73
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 73
DNA Vaccines Targeting Tumor Antigens to B7 Molecules on Antigen-Presenting Cells Induce Protective Antitumor Immunity and Delay Onset of HER-2/Neu-Driven Mammary Carcinoma 68
Anaplastic lymphoma kinase: an oncogene for tumor vaccination 65
Intramammary Application of Non-Methylated-CpG Oligodeoxynucleotides (CpG) Inhibits both Local and Systemic Mammary Carcinogenesis in Female BALB/c Her-2/neu Transgenic Mice 61
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer 61
ErbB2 transgenic mice: a tool for investigation of the immune prevention and treatment of mammary carcinomas 11
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma 10
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer 8
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 4
Totale 1.406
Categoria #
all - tutte 4.225
article - articoli 0
book - libri 0
conference - conferenze 242
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020187 6 8 8 20 9 21 21 8 26 21 24 15
2020/2021207 7 15 15 6 24 7 20 12 30 28 10 33
2021/2022184 9 9 5 15 6 3 16 9 10 12 55 35
2022/2023327 30 41 3 35 25 81 19 20 40 11 12 10
2023/2024149 20 21 6 5 8 25 2 20 0 13 15 14
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.406